Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Secretol vs Nexium in GERD with Severe Erosive Esophagitis
NCT01129713Phase 2Unknown
- Sponsor
- Effexus Pharmaceutical
- Start
- May 2010
- Primary completion
- May 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of secretin in gastroesophageal reflux disease (GERD), erosive esophagitis (EE), sponsored by Effexus Pharmaceutical. Status: unknown.
02
Drugs
secretin
03
Conditions
gastroesophageal reflux disease (GERD)erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT01129713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01129713.